Academic and clinical interest in noninvasive ventilation (NIV) for the treatment of acute respiratory failure (ARF) is high (Figure 1). The NIV isn’t often used. The evidence overwhelmingly favors its usage in those who are experiencing COPD (chronic obstructive pulmonary disease) exacerbations and people who have acute cardiogenic pulmonary edema. Acute and chronic respiratory illnesses were the cause of 8% of child fatalities, 20% of weekly GP visits, and 15% of hospital admissions in the UK in 2001 . Increased proof of efficacy, advancements in ventilator technology, and pediatric user interface design, as well as public and physician awareness, are all potential contributing factors. Numerous of these kids were raised at home [2, 3].